Keywords:
CELLS
;
resistance
;
CROSS-RESISTANCE
;
CHRONIC MYELOGENOUS LEUKEMIA
;
CANCER-THERAPY
;
17- allylamino-geldanamycin (17-AAG)
;
chronic myelogenous leukaemia
;
heat shock protein 90 (Hsp90)
;
imatinib mesylate (STI571)
;
ST1571
Type of Publication:
Journal article published
Deep Link:
http://www.dkfz.de/cgi-bin/sel?http://www.dkfz.de/PublicationManager/Show/ShowJournal.aspx%3fpublishedId=731